TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[41] Lower risk of hepatocellular carcinoma among patients with chronic hepatitis B treated with tenofovir than entecavir
Young-Suk Lim
Cancer Biology & Medicine, 2018, 15(S1) (S1) : 19 - 20
[42] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Reply
Yip, Terry Cheuk-Fung
Wong, Grace Lai-Hung
GASTROENTEROLOGY, 2020, 158 (08) : 2312 - 2313
[43] Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
Yu, Jung Hwan
Jin, Young-Joo
Lee, Jin-Woo
Lee, Don-Haeng
HEPATOLOGY RESEARCH, 2018, 48 (11) : 862 - 871
[44] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee
Young Youn Cho
Hyein Lee
Jae Seung Lee
Seung Up Kim
Jun Yong Park
Do Young Kim
Sang Hoon Ahn
Beom Kyung Kim
Soo Young Park
Hepatology International, 2021, 15 : 1083 - 1092
[45] Hepatitis B: Tenofovir is superior than Entecavir for treating Patients with Hepatocellular Carcinoma
Lorenz, Judith
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (08):
[46] Chronic Hepatitis B: Tenofovir and Entecavir compared
Kessing, Richard
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
[47] Entecavir versus tenofovir disoproxil fumarate on the reduction of incidence of hepatocellular carcinoma in patients with chronic hepatitis B-related liver cirrhosis
Lin, Yu-Hung
Lai, Huang-Lun
Wang, Chun-Hsiang
Chang, Kuo-Kuan
Mo, Lein-Ray
Lin, Ruey-Chang
ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (01) : 16 - 23
[48] Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
Gu, Lihu
Yao, Qigu
Shen, Zefeng
He, Ying
Ng, Derry Minyao
Yang, Tong
Chen, Bangsheng
Chen, Ping
Mao, Feiyan
Yu, Qili
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1467 - 1476
[49] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Dave, Shravan
Park, Sooyoung
Murad, M. Hassan
Barnard, Abbey
Prokop, Larry
Adams, Leon A.
Singh, Siddharth
Loomba, Rohit
HEPATOLOGY, 2021, 73 (01) : 68 - 78
[50] Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
Kao, Wei-Yu
Tan, Elise Chia-Hui
Lee, Hsin-Lun
Huang, Yi-Hsiang
Huo, Teh-Ia
Chang, Chun-Chao
Chiou, Jeng-Fong
Hou, Ming-Chih
Wu, Jaw-Ching
Su, Chien-Wei
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1299 - 1312

← 1 2 3 4 5 →